• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Certain BlackRock Sector Equity Closed-End Funds Announce Updates to Investment Objectives and Principal Investment Strategies

    9/10/25 6:15:00 PM ET
    $BCX
    $BGR
    $BME
    $BMEZ
    Finance/Investors Services
    Finance
    Trusts Except Educational Religious and Charitable
    Finance
    Get the next $BCX alert in real time by email

    The BlackRock Sector Equity Closed End Funds (CEFs) listed below (the "Funds") announced today that each Fund's Board of Trustees (the "Board") has approved the following updates to the Funds' respective investment objectives and principal investment strategies.

    Effective 11/10/2025, the Funds' investment objectives will be changed as indicated below.

    Investment objective changes

    BlackRock Sector CEFs

     

    Ticker

     

    Current Investment Objective

     

    Proposed Investment Objective

    BlackRock Resources and Commodities Strategy Trust

     

    BCX

     

    The Trust's primary investment objective is to seek high current income and current gains, with a secondary objective of capital appreciation.

     

    The Trust's investment objectives are to provide total return and income through a combination of current income and long-term capital appreciation.

    BlackRock Energy and Resources Trust

     

    BGR

     

    The Trust's investment objective is to provide total return through a combination of current income and capital appreciation.

     

    The Trust's investment objectives are to provide total return and income through a combination of current income and long-term capital appreciation.

    BlackRock Utilities, Infrastructure and Power Opportunities Trust

     

    BUI

     

    The Trust's investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation.

     

    The Trust's investment objectives are to provide total return and income through a combination of current income and long-term capital appreciation.

    BlackRock Health Sciences Trust

     

    BME

     

    The Trust's investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation.

     

    The Trust's investment objectives are to provide total return and income primarily through long-term capital appreciation.

    BlackRock Health Sciences Term Trust

     

    BMEZ

     

    The Trust's investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation.

     

    The Trust's investment objectives are to provide total return and income primarily through long-term capital appreciation.

    BlackRock Science and Technology Trust

     

    BST

       

    BlackRock Science and Technology Term Trust

     

    BSTZ

       

    BlackRock Technology and Private Equity Term Trust

     

    BTX

       

    Investment strategy update

    In addition to changing the Funds' respective investment objectives, each Board also approved changing the Funds' principal investment strategies to remove the options writing strategy. BlackRock Advisors, LLC ("BlackRock"), each Fund's investment advisor, believes the removal of such strategy will better align the Funds' principal investment strategies with shareholder interests and expectations for equity closed-end funds. In addition, BlackRock believes that removing the options writing strategy has the potential to allow each fund to capture more capital appreciation, with the goal of outperforming broad equity indices over a full cycle using the benefits of the closed-end fund structure. The Funds' updated strategies could also potentially lead to greater distribution stability, improved trading and lower discounts.

    About BlackRock

    BlackRock's purpose is to help more and more people experience financial well-being. As a fiduciary to investors and a leading provider of financial technology, we help millions of people build savings that serve them throughout their lives by making investing easier and more affordable. For additional information on BlackRock, please visit www.blackrock.com/corporate.

    Availability of Fund Updates

    BlackRock will update performance and certain other data for each Fund on a monthly basis on its website in the "Closed-end Funds" section of www.blackrock.com as well as certain other material information as necessary from time to time. Investors and others are advised to check the website for updated performance information and the release of other material information about each Fund. This reference to BlackRock's website is intended to allow investors public access to information regarding each Fund and does not, and is not intended to, incorporate BlackRock's website in this release.

    Forward-Looking Statements

    This press release, and other statements that BlackRock or a Fund may make, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to the Fund's or BlackRock's future financial or business performance, strategies or expectations. Forward-looking statements are typically identified by words or phrases such as "trend," "potential," "opportunity," "pipeline," "believe," "comfortable," "expect," "anticipate," "current," "intention," "estimate," "position," "assume," "outlook," "continue," "remain," "maintain," "sustain," "seek," "achieve," and similar expressions, or future or conditional verbs such as "will," "would," "should," "could," "may" or similar expressions.

    BlackRock cautions that forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and BlackRock assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and future results could differ materially from historical performance.

    With respect to the Funds, the following factors, among others, could cause actual events to differ materially from forward-looking statements or historical performance: (1) changes and volatility in political, economic or industry conditions, the interest rate environment, foreign exchange rates or financial and capital markets, which could result in changes in demand for a Fund or in a Fund's net asset value; (2) the relative and absolute investment performance of a Fund and its investments; (3) the impact of increased competition; (4) the unfavorable resolution of any legal proceedings; (5) the extent and timing of any distributions or share repurchases; (6) the impact, extent and timing of technological changes; (7) the impact of legislative and regulatory actions and reforms, and regulatory, supervisory or enforcement actions of government agencies relating to a Fund or BlackRock, as applicable; (8) terrorist activities, international hostilities, health epidemics and/or pandemics and natural disasters, which may adversely affect the general economy, domestic and local financial and capital markets, specific industries or BlackRock; (9) BlackRock's ability to attract and retain highly talented professionals; (10) the impact of BlackRock electing to provide support to its products from time to time; and (11) the impact of problems at other financial institutions or the failure or negative performance of products at other financial institutions.

    Annual and Semi-Annual Reports and other regulatory filings of the Funds with the Securities and Exchange Commission ("SEC") are accessible on the SEC's website at www.sec.gov and on BlackRock's website at www.blackrock.com, and may discuss these or other factors that affect the Funds. The information contained on BlackRock's website is not a part of this press release.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250910633094/en/

    1-800-882-0052

    Get the next $BCX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BCX
    $BGR
    $BME
    $BMEZ

    CompanyDatePrice TargetRatingAnalyst
    BlackRock Technology and Private Equity Term Trust
    $BTX
    12/29/2021$9.00Overweight
    Cantor Fitzgerald
    BlackRock Technology and Private Equity Term Trust
    $BTX
    10/6/2021$20.00Buy
    Maxim Group
    More analyst ratings

    $BCX
    $BGR
    $BME
    $BMEZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Brooklyn with a new price target

    Cantor Fitzgerald initiated coverage of Brooklyn with a rating of Overweight and set a new price target of $9.00

    12/29/21 7:03:49 AM ET
    $BTX

    Maxim Group initiated coverage on Brooklyn ImmunoTherapeutics with a new price target

    Maxim Group initiated coverage of Brooklyn ImmunoTherapeutics with a rating of Buy and set a new price target of $20.00

    10/6/21 7:53:44 AM ET
    $BTX

    $BCX
    $BGR
    $BME
    $BMEZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Saba Capital Management, L.P. disposed of $454,458,709 worth of shares (60,675,395 units at $7.49) (SEC Form 4)

    4 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)

    7/10/25 3:48:00 PM ET
    $BTX

    SEC Form 3 filed by new insider Minar Stephen Thomas

    3 - BlackRock Resources & Commodities Strategy Trust (0001506289) (Issuer)

    5/16/25 4:30:51 PM ET
    $BCX
    Finance/Investors Services
    Finance

    New insider Minar Stephen Thomas claimed ownership of 7,745 shares (SEC Form 3)

    3 - BlackRock Science & Technology Term Trust (0001768666) (Issuer)

    5/16/25 4:27:43 PM ET
    $BSTZ
    Trusts Except Educational Religious and Charitable
    Finance

    $BCX
    $BGR
    $BME
    $BMEZ
    SEC Filings

    View All

    SEC Form N-CSRS filed by BlackRock Science and Technology Trust

    N-CSRS - BlackRock Science & Technology Trust (0001616678) (Filer)

    9/4/25 4:56:03 PM ET
    $BST
    Finance Companies
    Finance

    SEC Form N-CSRS filed by BlackRock Resources

    N-CSRS - BlackRock Resources & Commodities Strategy Trust (0001506289) (Filer)

    9/4/25 4:49:52 PM ET
    $BCX
    Finance/Investors Services
    Finance

    SEC Form N-CSRS filed by BlackRock Health Sciences Term Trust

    N-CSRS - BlackRock Health Sciences Term Trust (0001785971) (Filer)

    9/4/25 4:42:08 PM ET
    $BMEZ
    Trusts Except Educational Religious and Charitable
    Finance

    $BCX
    $BGR
    $BME
    $BMEZ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Portfolio Manager Kim Tony bought $501,390 worth of shares (27,000 units at $18.57), increasing direct ownership by 16% to 193,533 units (SEC Form 4)

    4 - BlackRock Science & Technology Term Trust (0001768666) (Issuer)

    3/14/25 4:39:29 PM ET
    $BSTZ
    Trusts Except Educational Religious and Charitable
    Finance

    Portfolio Manager Kim Tony bought $398,038 worth of shares (10,264 units at $38.78), increasing direct ownership by 33% to 41,514 units (SEC Form 4)

    4 - BlackRock Science & Technology Trust (0001616678) (Issuer)

    2/21/25 4:44:47 PM ET
    $BST
    Finance Companies
    Finance

    Portfolio Manager Kim Tony bought $931,387 worth of shares (24,000 units at $38.81), increasing direct ownership by 331% to 31,250 units (SEC Form 4)

    4 - BlackRock Science & Technology Trust (0001616678) (Issuer)

    2/19/25 2:52:40 PM ET
    $BST
    Finance Companies
    Finance

    $BCX
    $BGR
    $BME
    $BMEZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BlackRock Announces Update to BMEZ, BSTZ, and BTX Managed Distribution Plans

    The Board of Trustees (the "Board") of BlackRock Health Sciences Term Trust (BMEZ), BlackRock Science and Technology Term Trust (BSTZ), and BlackRock Technology and Private Equity Term Trust (BTX) (the "Funds") approved updates to each Fund's managed distribution plan that will take effect with the October 2025 distribution. The Funds will change from a floating rate distribution to a level rate distribution at the stated monthly rates provided below. These changes seek to enhance distribution stability while maintaining a competitive distribution rate and offering the potential to grow each Fund's net asset value. Additionally, these changes will help to manage the proportion of public and

    9/10/25 8:06:00 PM ET
    $BMEZ
    $BSTZ
    $BTX
    Trusts Except Educational Religious and Charitable
    Finance

    Certain BlackRock Sector Equity Closed-End Funds Announce Updates to Investment Objectives and Principal Investment Strategies

    The BlackRock Sector Equity Closed End Funds (CEFs) listed below (the "Funds") announced today that each Fund's Board of Trustees (the "Board") has approved the following updates to the Funds' respective investment objectives and principal investment strategies. Effective 11/10/2025, the Funds' investment objectives will be changed as indicated below. Investment objective changes BlackRock Sector CEFs   Ticker   Current Investment Objective   Proposed Investment Objective BlackRock Resources and Commodities Strategy Trust   BCX   The Trust's primary investment objective is to seek high current income and current gains, with a secondary objective

    9/10/25 6:15:00 PM ET
    $BCX
    $BGR
    $BME
    Finance/Investors Services
    Finance
    Trusts Except Educational Religious and Charitable
    Finance Companies

    Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

    Certain BlackRock closed-end funds (the "Funds") announced distributions today as detailed below. Municipal Funds: Declaration- 9/2/2025 Ex-Date- 9/15/2025 Record- 9/15/2025 Payable- 10/1/2025     National Funds     Ticker     Distribution Change From Prior Distribution   BlackRock Municipal Income Quality Trust*   BYM   $0.055500   - BlackRock Long-Term Municipal Advantage Trust* BTA $0.049500 - BlackRock MuniAssets Fund, Inc.* MUA $0.055500 - BlackRock Municipal Income Trust* BFK $0.050000 - BlackRock Investment Q

    9/2/25 5:26:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    $BCX
    $BGR
    $BME
    $BMEZ
    Leadership Updates

    Live Leadership Updates

    View All

    Brooklyn ImmunoTherapeutics Announces Changes to Executive Management: Matt Angel, Ph.D. Appointed Interim Chief Executive Officer and President, Andrew Jackson Appointed Chief Financial Officer Postpones 2022 Annual Meeting

    SAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NASDAQ:BTX) ("Brooklyn" or the "Company"), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have on the immune system for treating patients with cancer, blood disorders, and monogenic diseases, today announced the appointment of Matt Angel, Ph.D., Co-Founder, Chairman, and CEO of Factor Bioscience Inc., as Interim Chief Executive Officer and President. He will replace Howard J. Federoff, M.D., Ph.D., Chief Executive Officer and President, who departs to focus on building a new venture. The Company also announces the appointment of Andrew Jackson as Chief

    5/31/22 7:30:00 AM ET
    $BTX

    Amarin Announces Appointment of New Directors and Board Leadership Changes

    Erin Enright and Alfonso "Chito" Zulueta Appointed to Board of Directors New Board Members Bring Skills and Experience Aligned with the Company's Strategy Per Wold-Olsen Named Chairman of the Board David Stack and Joe Zakrzewski to Retire from the Board Actions Reflect Company and Board's Commitment to Ongoing Refreshment and Enhancement DUBLIN, Ireland and BRIDGEWATER, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced a series of appointments and leadership changes to its Board of Directors, including: Appointment of Erin Enright and Alfonso "Chito" Zulueta to the Board, effective immediately. Ms. Enright and Mr. Zulueta will sta

    5/19/22 8:23:13 AM ET
    $AMRN
    $BTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Brooklyn ImmunoTherapeutics Welcomes Erin S. Enright and Heather B. Redman to Its Board of Directors

    NEW YORK, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NASDAQ:BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announces the appointment of two new members of the Company's Board of Directors. Erin S. Enright has served on multiple Boards of Directors, including within the medical and life sciences arenas, such as Keystone Dental (serving as Audit Committee Chair), Medical Facilities Corporation (serving as Audit and Investment Committee Chair), and Dynatronics Corporation (serving on the Audit, Compensati

    1/20/22 7:30:00 AM ET
    $BTX

    $BCX
    $BGR
    $BME
    $BMEZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by BlackRock Energy and Resources Trust

    SC 13G/A - BlackRock Energy & Resources Trust (0001306550) (Subject)

    12/6/24 4:01:02 PM ET
    $BGR
    Trusts Except Educational Religious and Charitable
    Finance

    SEC Form SC 13G filed by BlackRock Energy and Resources Trust

    SC 13G - BlackRock Energy & Resources Trust (0001306550) (Subject)

    11/14/24 4:06:32 PM ET
    $BGR
    Trusts Except Educational Religious and Charitable
    Finance

    Amendment: SEC Form SC 13D/A filed by BlackRock Health Sciences Term Trust

    SC 13D/A - BlackRock Health Sciences Term Trust (0001785971) (Subject)

    10/11/24 3:22:20 PM ET
    $BMEZ
    Trusts Except Educational Religious and Charitable
    Finance

    $BCX
    $BGR
    $BME
    $BMEZ
    Financials

    Live finance-specific insights

    View All

    Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

    Certain BlackRock closed-end funds (the "Funds") announced distributions today as detailed below. Municipal Funds: Declaration- 9/2/2025 Ex-Date- 9/15/2025 Record- 9/15/2025 Payable- 10/1/2025     National Funds     Ticker     Distribution Change From Prior Distribution   BlackRock Municipal Income Quality Trust*   BYM   $0.055500   - BlackRock Long-Term Municipal Advantage Trust* BTA $0.049500 - BlackRock MuniAssets Fund, Inc.* MUA $0.055500 - BlackRock Municipal Income Trust* BFK $0.050000 - BlackRock Investment Q

    9/2/25 5:26:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

    Today, BlackRock Resources & Commodities Strategy Trust (NYSE:BCX), BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ), BlackRock Energy and Resources Trust (NYSE:BGR), BlackRock Enhanced International Dividend Trust (NYSE:BGY), BlackRock Health Sciences Trust (NYSE:BME), BlackRock Health Sciences Term Trust (NYSE:BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE:BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE:BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE:CII), BlackRock Science and Technology Trust (NYSE:BST), BlackRock Science and Technology Term Trust (NYSE:BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE:BTX), BlackRock Capital

    8/29/25 4:30:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

    Certain BlackRock closed-end funds (the "Funds") announced distributions today as detailed below. Municipal Funds: Declaration- 8/1/2025 Ex-Date- 8/15/2025 Record- 8/15/2025 Payable- 9/2/2025 National Funds Ticker Distribution Change From Prior Distribution BlackRock Municipal Income Quality Trust* BYM $0.055500 - BlackRock Long-Term Municipal Advantage Trust* BTA $0.049500 - BlackRock MuniAssets Fund, Inc.* MUA $0.055500 - BlackRock Municipal Income Trust* BFK $0.050000 - BlackRock Investment Quality Municipal Trust, Inc.* BKN $0.057000

    8/1/25 4:30:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable